NPM1 and prostate carcinoma: Although NPM is frequently mutated in acute myeloid leukemias [12], it is higher expression in many types of human solid tumors, and it has been proposed as a marker for colon, liver, stomach, ovary, thyroid and prostate carcinoma [3, 13–17].